- Home
- INMB vs PAI Comparison
INMB vs PAI Comparison
Compare INMB & PAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INMB
- PAI
- Stock Information
- Founded
- INMB 2015
- PAI 1973
- Country
- INMB United States
- PAI United States
- Employees
- INMB N/A
- PAI N/A
- Industry
- INMB Biotechnology: Pharmaceutical Preparations
- PAI Trusts Except Educational Religious and Charitable
- Sector
- INMB Health Care
- PAI Finance
- Exchange
- INMB Nasdaq
- PAI Nasdaq
- Market Cap
- INMB 176.5M
- PAI N/A
- IPO Year
- INMB 2019
- PAI N/A
- Fundamental
- Price
- INMB $2.10
- PAI $13.02
- Analyst Decision
- INMB Buy
- PAI
- Analyst Count
- INMB 4
- PAI 0
- Target Price
- INMB $16.87
- PAI N/A
- AVG Volume (30 Days)
- INMB 6.0M
- PAI 25.0K
- Earning Date
- INMB 07-31-2025
- PAI 01-01-0001
- Dividend Yield
- INMB N/A
- PAI 4.78%
- EPS Growth
- INMB N/A
- PAI N/A
- EPS
- INMB N/A
- PAI N/A
- Revenue
- INMB $50,000.00
- PAI N/A
- Revenue This Year
- INMB $82.14
- PAI N/A
- Revenue Next Year
- INMB $28,750.98
- PAI N/A
- P/E Ratio
- INMB N/A
- PAI N/A
- Revenue Growth
- INMB N/A
- PAI N/A
- 52 Week Low
- INMB $1.89
- PAI $10.59
- 52 Week High
- INMB $11.64
- PAI $12.63
- Technical
- Relative Strength Index (RSI)
- INMB 21.99
- PAI 78.24
- Support Level
- INMB $5.60
- PAI $12.35
- Resistance Level
- INMB $11.64
- PAI $12.51
- Average True Range (ATR)
- INMB 1.18
- PAI 0.12
- MACD
- INMB -0.55
- PAI 0.06
- Stochastic Oscillator
- INMB 1.01
- PAI 79.07
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.